1Graduate School of Innovative Life Science, University of Toyama, 3190 Gofuku, Toyama 930-8555, Japan.
J Physiol. 2013 Mar 1;591(5):1295-312. doi: 10.1113/jphysiol.2012.247676. Epub 2012 Dec 24.
Cholecystokinin (CCK) is a hypothetical controller for suckling and infancy body weight, although the underlying mechanisms remain unclear. Therefore, the present study analysed the mechanisms using mice lacking the CCK-1 receptor (CCK1R-/-). Although CCK1R-/- mice displayed normal weights at birth and adulthood, CCK1R-/- pups had enlarged adipocytes and were overweight from the first to second week after birth, regardless of maternal genotype. The lacZ reporter gene assay and/or calcium imaging analysis demonstrated that CCK-1 receptors were abundant in satiety-controlling regions such as the hypothalamus, brainstem, nodose ganglion and pylorus in adults, whereas these signals were few to lacking at pre-weanling stages. At postnatal day (PD) 6, the increase in cFos expression in the medullary nucleus tractus solitarius was similarly triggered by gastrointestinal milk- or saline filling in both genotypes, further indicating immature CCK-1 receptor function in an ascending satiety-controlling system during infancy. Conversely, third ventricle ependymal tanycyte-like cells expressed CCK-1 receptors with expression peaking at PD6. At PD6, wild-type but not CCK1R-/- mice had increased cFos immunoreactivity in ependymal cells following gastrointestinal milk filling whereas the response became negligible at PD12. In addition, ependymal cFos was not increased by saline filling, indicating that these responses are dependent on CCK-1 receptors, developmental stage and nutrients. Furthermore, body weights of wild-type pups were transiently increased by blocking ependymal CCK receptor function with microinjection of a CCK-1 antagonist, but not a CCK-2 antagonist. Hence, we demonstrate de novo functions of ependymal CCK-1 receptors and reveal a new aspect of infant satiety-controlling mechanisms.
胆囊收缩素(CCK)是一种假设的哺乳和婴儿期体重控制器,尽管其潜在机制仍不清楚。因此,本研究使用缺乏 CCK-1 受体(CCK1R-/-)的小鼠来分析这些机制。虽然 CCK1R-/-小鼠在出生和成年时体重正常,但 CCK1R-/-幼鼠出生后第一周到第二周体重增加,脂肪细胞增大,超重,无论母鼠的基因型如何。lacZ 报告基因检测和/或钙成像分析表明,CCK-1 受体在控制饱腹感的区域(如下丘脑、脑干、结状神经节和幽门)中大量存在,而在未断奶阶段,这些信号很少或缺如。在出生后第 6 天(PD6),胃肠道牛奶或盐水填充在两种基因型中均能同样触发孤束核的 cFos 表达增加,进一步表明在婴儿期,CCK-1 受体在上升的饱腹感控制系统中的功能不成熟。相反,第三脑室室管膜下的 tanycyte 样细胞表达 CCK-1 受体,在 PD6 时表达达到峰值。在 PD6 时,野生型小鼠而非 CCK1R-/-小鼠在胃肠道牛奶填充后室管膜细胞中的 cFos 免疫反应性增加,而在 PD12 时反应变得微不足道。此外,盐水填充不会增加室管膜 cFos,表明这些反应依赖于 CCK-1 受体、发育阶段和营养物质。此外,用 CCK-1 拮抗剂微注射阻断室管膜 CCK 受体功能会使野生型幼鼠的体重短暂增加,但用 CCK-2 拮抗剂则不会。因此,我们证明了室管膜 CCK-1 受体的新功能,并揭示了婴儿饱腹感控制机制的一个新方面。